INF2 and endometrial cancer: Furthermore, by using endogenous antibodies to precipitate INF2 protein from HEC-1B and Ishikawa endometrial cancer cells, we confirmed the presence of endogenous AMPKα1/α2 protein (Fig. 3B, Supplementary Fig. 4A).